GSK stock trades at EUR 20.81 with USD 93.2 billion value

Published on 10/09/2026 at 15:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GSK stock traded at EUR 20.81 on October 9, 2026, up 0.24 percent from EUR 20.76. Results are due October 28, 2026.

Key points in brief

GSK stock traded at EUR 20.81 at Lang & Schwarz on October 9, 2026, up 0.24 percent from the prior close.
Market capitalization stood at USD 93.2 billion and the price-to-earnings ratio was 14.81.
MarketBeat reported a Hold consensus and average target of GBp 2,064.38 on October 7, 2026.
GSK's next results date is October 28, 2026, according to Simply Wall St.

Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht — GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK stock traded at EUR 20.81 at Lang & Schwarz on October 9, 2026 at 3:36 p.m. CEST, up 0.24 percent from the prior close of EUR 20.76. Global Banking and Finance identifies GSK.L as the London Stock Exchange ticker for GSK plc and assigns ISIN GB00BN7SWP63 to the ordinary shares.

Intraday spread stays narrow

The Lang & Schwarz bid was EUR 20.79 and the ask was EUR 20.82 at the quoted time. That 3-cent spread places the midpoint at EUR 20.805, only EUR 0.005 below the last traded price, while the daily move remained below 1.00 percent.

The wider market snapshot points to 682,672 shares in volume against an average of 3,852,382 shares for the quoted GSK instrument on October 9, 2026. Volume was therefore 82.29 percent below the average, a useful distinction from the modest price gain.

Valuation carries the report

GSK's market capitalization was USD 93.2 billion on October 9, 2026, and the price-to-earnings ratio stood at 14.81. These two figures frame the session more clearly than the 0.24 percent daily move: the stock held its level while the valuation remained measurable against current earnings.

MarketBeat reported a Hold consensus and an average target of GBp 2,064.38 on October 7, 2026. The target is stated in pence for the London listing and is not combined with the euro quotation.

Comparison with peers

GSK (LSE, GBp): plus 0.24 percent, P/E 14.81, market capitalization USD 93.2 billion

AstraZeneca (Nasdaq, USD): plus 0.26 percent, P/E 23.86, market capitalization USD 246.9 billion

Gilead Sciences (Nasdaq, USD): plus 0.68 percent, P/E minus 55.51, market capitalization USD 183.6 billion

Results date is October 28

Simply Wall St lists October 28, 2026 as GSK's next results date. The same source says second-quarter 2026 revenue exceeded analyst expectations, while earnings per share fell to GBP 0.11 from GBP 0.35 in the second quarter of 2025, giving the calendar date a clear fundamental reference.

Price holds above the prior close

At EUR 20.81, GSK was EUR 0.05 above its Lang & Schwarz prior close of EUR 20.76 on October 8, 2026. The session's small gain, lower quoted volume and the October 28 reporting date define the immediate market setup.

The further course of trading is shown by the continuously updated real-time quote of GSK stock.